Dr Cho Rong Hong

Research Fellow

In: Auckland Cancer Society Research Centre » Medical Science » Faculty of Medical and Health Sciences

Selected publications and creative works (Research Outputs)

Hong, C. R., Wilson, W. R., & Hicks, K. O. (2019). An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect. Neoplasia (New York, N.Y.), 21 (2), 159-171. 10.1016/j.neo.2018.11.009
Other University of Auckland co-authors: Kevin Hicks
Mao, X., McManaway, S., Jaiswal, J. K., Hong, C. R., Wilson, W. R., & Hicks, K. O. (2019). Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000. Cancer biology & therapy, 20 (9), 1258-1269. 10.1080/15384047.2019.1617570
Other University of Auckland co-authors: Jagdish Jaiswal, Kevin Hicks
Hong, C. R., Dickson, B. D., Jaiswal, J. K., Pruijn, F. B., Hunter, F. W., Hay, M. P., ... Wilson, W. R. (2018). Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects. Biochemical Pharmacology, 156, 265-280. 10.1016/j.bcp.2018.08.027
Other University of Auckland co-authors: Benjamin Dickson, Michael Hay, Jagdish Jaiswal, Frederik Pruijn, Francis Hunter, Kevin Hicks
Jamieson, S. M., Tsai, P., Kondratyev, M. K., Budhani, P., Liu, A., Senzer, N. N., ... Kee, D. (2018). Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma. JCI insight, 3 (16).10.1172/jci.insight.122204
Other University of Auckland co-authors: Francis Hunter, Stephen Jamieson, Peter Tsai, Avik Shome, Way Wong, Nicholas Knowlton, Tet Woo Lee, Kevin Hicks, Stefan Bohlander, Purvi Kakadiya, Cristin Print, Courtney Lynch, Nooriyan Poonawala-Lohani
Hong, C. R. (2018). Investigation of bystander effects of hypoxia-activated prodrugs using three dimensional cell cultures The University of Auckland. ResearchSpace@Auckland.
Hong, C. R., Bogle, G., Wang, J., Patel, K., Pruijn, F. B., Wilson, W. R., & Hicks, K. O. (2018). Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures. Frontiers in pharmacology, 910.3389/fphar.2018.01013
Other University of Auckland co-authors: Kevin Hicks, Gib Bogle, Frederik Pruijn
Bonnet, M., Hong, C. R., Wong, W. W., Liew, L. P., Shome, A., Wang, J., ... Anderson, R. F. (2018). Next-generation hypoxic cell radiosensitizers: Nitroimidazole alkylsulfonamides. Journal of Medicinal Chemistry, 61 (3), 1241-1254. 10.1021/acs.jmedchem.7b01678
Other University of Auckland co-authors: Michael Hay, Lydia Liew, Way Wong, Bob Anderson, Stephen Jamieson, Kevin Hicks, Frederik Pruijn, Yongchuan Gu, Avik Shome
Hunter, F., Shome, A., Wong, W. W., Budhani, P., Senzer, N., Chiorean, E. G., ... Kakadiya, P. (2017). Efficacy and sensitivity determinants of evofosfamide in head and neck squamous cell carcinoma. Paper presented at The New Zealand Society for Oncology 2017 Conference, Auckland, New Zealand. 14 October - 15 October 2017.
Other University of Auckland co-authors: Francis Hunter, Avik Shome, Way Wong, Nooriyan Poonawala-Lohani, Purvi Kakadiya, Courtney Lynch, Tet Woo Lee, Kevin Hicks, Stefan Bohlander, Cristin Print, Stephen Jamieson